CIK 0001042418 · Non-accelerated filer<br>Smaller reporting company
Inhibitor Therapeutics, Inc.
Sign in to watch- Ticker
- INTI
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 541641133
- Phone
- (813) 766-2462
- Business address
- 4830 W. KENNEDY BLVD., SUITE 600, TAMPA, FL, 33609
- Former names
- HedgePath Pharmaceuticals, Inc., COMMONWEALTH BIOTECHNOLOGIES INC
- 4 Open-market buy Director bought 12,000 shares at $0.40 ($4,800)
- 4 Open-market buy Director bought 3,310 shares at an average $0.40 ($1,314)
- 4 Open-market buy Director bought 50,006 shares at an average $0.35 ($17,487)
- 4 Grant or award Executive VP acquired 25,000 shares (grant or award)
- 4 Grant or award President acquired 25,000 shares (grant or award)
- 4 Grant or award Chief Operating Officer acquired 25,000 shares (grant or award)
- 4 Grant or award VP Financial Operations acquired 25,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy COO bought 5,000 shares at $0.98 ($4,900)
- 4 Open-market sale 10% owner sold 2,150,000 shares at $1.45 ($3,117,500)
- 3 Insider Initial Statement of Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 5 Insider Annual Insider Trading Report
- 5 Insider Annual Insider Trading Report
Page 7 of 11 · 219 filings